Accord Plasma B.V., une filiale d'Intas Pharmaceuticals, a annoncé aujourd'hui avoir conclu l'acquisition de Prothya ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results